{"filing":{"accession_number":"0001178913-26-004796","cik":"0001534248","ticker":"CMMB","company_name":"Chemomab Therapeutics Ltd.","form":"6-K","filing_date":"2026-10-19","report_date":"2026-10-19","primary_document":"zk2636237.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891326004796/zk2636237.htm"},"events":[{"id":36189,"run_id":33359,"accession_number":"0001178913-26-004796","anchor_item_number":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"The 6-K discloses Amendment No. 2 to the Domestication Merger Agreement dated October 16, 2026, which is a material step in Chemomab's redomiciliation and merger with Scipher Medicine Corporation. The amendment adjusts the Domestication Exchange Ratio and reduces post-closing shares from 10,000,000 to 5,000,000, and modifies the CVR Agreement terms. This constitutes a material amendment to an ongoing merger transaction that would significantly affect shareholder ownership and deal structure.","company_name":"Chemomab Therapeutics Ltd.","ticker":"CMMB","filing_date":"2026-10-19","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":40513,"accession_number":"0001178913-26-004796","item_number":null,"item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The 6-K discloses Amendment No. 2 to the Domestication Merger Agreement dated October 16, 2026, which is a material step in Chemomab's redomiciliation and merger with Scipher Medicine Corporation. The amendment adjusts the Domestication Exchange Ratio and reduces post-closing shares from 10,000,000 to 5,000,000, and modifies the CVR Agreement terms. This constitutes a material amendment to an ongoing merger transaction that would significantly affect shareholder ownership and deal structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-19T21:28:52.865107+00:00","company_name":"Chemomab Therapeutics Ltd.","ticker":"CMMB","filing_date":"2026-10-19"}]}